As for being a home run or not. We know that Leronlimab
As for being a home run or not. We know that Leronlimab works and when and how much in dose size and how often are all things the doctors can justify and prescribe as we go forward once we have a BLA. We just need to show that we work to get a EUA. If we continue to just trial for each different Covid-19 level of disease. It will be a while before we see wide spread use. Who knows... maybe we work best if we dose at Moderate and half the normal rate of SOC/placebo patients continue to Severe and then we dose again and half of those patients don’t go to critical. Then we continue to dose the critical one dose every day until nobody dies. These are possibilities for doctors to try and not left up to trials when we get a BLA. It’s far to slow to continue trials for every covid indication and to many people will die before we get through all the trials possible we can think up for dosing and length of time between.
Good doctors will figure this all out by lab results and being attentive to their occupation as doctors. If our safety continues its golden path and is what we believe it will be going forward. Then Leronlimab could work excellent for Covid. Trials won’t necessarily show all the potential we hope to see. But use in the pandemic will be written about in journals and advertised or spoken about in presentations or even word of mouth social media throughout the medical field.
We just need to get over the hump on the first trial EUA approved before we learn just what Leronlimab can actually do during this early stages of this pandemic. For this, I am excited to see the potential. We are not limited overall by only one or two early trial results. It’s just the beginning of use is all. The door will be opened for more extensive use when we get BLA approval. Then we will all figure out just how good Leronlimab is. This is what I hope will shine through for us all. A drug that works and saves lives. How it is administered or how often we dose it, should be left up to the professionals. Safety will dictate the use of Leronlimab. Let’s hope our safety record holds true. This is the most important aspect going forward as an investor or a patient. As safety allows more of a universal common sense use and ability to change doses and time between doses as doctors dial in the proper use of any drug.
4
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Jollibee Partners with DreamWorks Animation Never thought I’d see the day: Jollibee, that familiar face of fast food, teaming up with the creative juggernaut DreamWorks Animation. They’re calling it a celebration of friendship and Filipino culture, wrapped up neatly in the context of a flick called Forgotten Island. Set to sizzle in theaters on September 25, 2026,...
Continue Reading
A Billion-Dollar Boost for Stoke Space Ever catch wind of a company hauling in a cool billion and shrug it off? Me neither. Stoke Space Technologies just locked down $1 billion in Series E funding. This ain't some pocket change—the kind of dough you need when you're eyeing stars and plotting orbital voyages. They're gearing up for a 2027 mission with their Nova...
Continue Reading
Transforming Old to New on the Runway Right when you think fashion's all about the next shiny thing, here comes Goodwill of Delaware & Delaware County flipping the script. Their ReThink Fashion Show - the ECO Edit teaches us a thing or two about what giving old clothes a new life truly means. It's not just about tossing a used tee onto a catwalk but a whole rebirth...
Continue Reading
Innovative Excellence in Healthcare Tech It's not every day you see a specialty group purchasing organization like AllyGPO snagging a spot on Fast Company's esteemed list of Best Workplaces for Innovators. Making it into the top half at number 40 in 2026, it’s a testament to a company really leaning into employee-driven innovation. And, buddy, this ain't just corporate...
Continue Reading
Series C Funding Ignites BrightPlan's Ambitions Ever seen a company that's ready to roll with the punches and come out stronger? That's BrightPlan for you. They're pushing the boundaries again, bagging new capital in this Series C round, steered by the seasoned folks over at ABS Capital Partners. Now, here's the thing: We're talking about a 230% revenue surge over just...
Continue Reading
Chasing the Dream on Wheels Amid the buzz of New York, there's a roar building up that's hard to ignore. It's a sound that echoes through time, capturing the imagination of petrol heads everywhere—those legendary American muscle cars are back in the limelight. I mean, who hasn't dreamt of launching down a highway in a '69 Ford Mustang? 'The Hunt for Rolling Treasure' is...
Continue Reading
Leidos' Autonomous Leap with the U.S. Navy Well, today it's all about Leidos, an outfit that's been showing its grit in the world of maritime autonomy. Their systems aren't just tinkering around anymore—they're slicing through the waves at RIMPAC, the Rim of the Pacific, and running alongside the USS Theodore Roosevelt Carrier Strike Group. That's big news in anyone's...
Continue Reading
When Two AI Giants Collide Every so often, we get a clash of titans in the business world, and this time it's in the AI universe. New York's Moonshot AI, a champ in autonomous website optimization, hit a bump when its name collided with a Chinese counterpart, also called Moonshot AI. And just like that, the NY company had to chuck their name out the window and don a new...
Continue Reading
A Seamless Transition in Austin's PostalAnnex Legacy You know when a business digs its roots deep, becoming more than just a place but a part of the community fabric? That's what’s playing out at the PostalAnnex on W Parmer Lane, Austin. After nearly two decades, this battered yet steadfast hub of office and shipping services is swapping hands, all in the name of...
Continue Reading
What a tangled web Illinois lawmakers have woven this time. They've gone and cooked up a pair of laws with a real knack for attracting attention—specifically from the folks over at the National Police Association (NPA). These aren’t your run-of-the-mill rules; they feel more like a blueprint for putting federal officers through the legal wringer and turning courtroom...
Continue Reading
Top 5 Most Recently Viewed Articles
Class Action Lawsuit Filed for Block, Inc. Investors Levi & Korsinsky, LLP has announced that they are representing investors who have faced losses due to alleged fraudulent activities by Block, Inc. This lawsuit primarily targets those who purchased shares of Block (NYSE: XYZ) during a defined period marked by significant legal and ethical issues. Understanding the Class...
Continue Reading
California Telecom Makes Its Mark on MSP 501 Who would've thought that a company could stand out so spectacularly in today's saturated tech industry? Well, that's exactly what California Telecom has done by snagging a spot on the 2026 MSP 501 list. This ain't just any old roll call; it's the benchmark for excellence, where managing service providers show their muscle not...
Continue Reading
CARV and MDEC Unite to Shape the Future of Gaming Malaysia is embarking on an ambitious journey to become a prominent digital gaming hub in Southeast Asia. This vision has been solidified through a strategic partnership between the Malaysia Digital Economy Corporation (MDEC) and EMERGE Group, with CARV taking center stage as a pioneer in data empowerment and blockchain...
Continue Reading
Provident Industrial's New Venture in Houston Provident Industrial is thrilled to announce the successful closing of the Eastex 59 development in Houston. This industrious endeavor focuses on creating a state-of-the-art industrial park that meets the growing needs of businesses looking for premium logistics solutions. Eastex 59 Overview Eastex 59 is envisioned as a...
Continue Reading
Fountain Life Unveils Exclusive Concierge Care Services Fountain Life, a leading name in longevity and preventative health, recently made a significant addition to its APEX Premium Longevity Membership. By integrating concierge care, the company now offers its members unmatched access to healthcare resources. With a focus on personalized health management, members can...
Continue Reading